These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26784861)

  • 1. Mesoporous silica nanoparticles in tissue engineering--a perspective.
    Rosenholm JM; Zhang J; Linden M; Sahlgren C
    Nanomedicine (Lond); 2016 Feb; 11(4):391-402. PubMed ID: 26784861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
    Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
    Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of mesoporous silica nanoparticles.
    Asefa T; Tao Z
    Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles for tissue-engineering applications.
    Chen L; Zhou X; He C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1573. PubMed ID: 31294533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
    Hu JJ; Xiao D; Zhang XZ
    Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
    Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
    Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shape-mediated biological effects of mesoporous silica nanoparticles.
    Hao N; Li L; Tang F
    J Biomed Nanotechnol; 2014 Oct; 10(10):2508-38. PubMed ID: 25992407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica nanoparticle surface chemistry: An important trait affecting cellular biocompatibility in two and three dimensional culture systems.
    Hasany M; Taebnia N; Yaghmaei S; Shahbazi MA; Mehrali M; Dolatshahi-Pirouz A; Arpanaei A
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110353. PubMed ID: 31336281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica nanoparticles in medicine--recent advances.
    Mamaeva V; Sahlgren C; Lindén M
    Adv Drug Deliv Rev; 2013 May; 65(5):689-702. PubMed ID: 22921598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
    Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
    Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bioimaging Applications of Mesoporous Silica Nanoparticles.
    Pratiwi FW; Kuo CW; Wu SH; Chen YP; Mou CY; Chen P
    Enzymes; 2018; 43():123-153. PubMed ID: 30244805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titania coating of mesoporous silica nanoparticles for improved biocompatibility and drug release within blood vessels.
    Farooq A; Shukur A; Astley C; Tosheva L; Kelly P; Whitehead D; Azzawi M
    Acta Biomater; 2018 Aug; 76():208-216. PubMed ID: 29933106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticle-based substrates for cell directed delivery of Notch signalling modulators to control myoblast differentiation.
    Böcking D; Wiltschka O; Niinimäki J; Shokry H; Brenner R; Lindén M; Sahlgren C
    Nanoscale; 2014; 6(3):1490-8. PubMed ID: 24316607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications.
    Liu J; Liu T; Pan J; Liu S; Lu GQM
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.